SAMUELSON PRODUCTIONS LIMITED

Financial Health Score: F (Critical Condition)

The patient is in a state of severe financial distress and is technically insolvent. Liabilities drastically exceed assets, and the company has virtually no cash reserves to sustain daily operations. It is currently surviving on artificial life support in the form of director loans. Without the continued, indefinite financial backing of its directors, the business would face immediate fatal complications.

Key Vital Signs

• Net Assets (Blood Pressure): -£756,635 — A dangerously negative reading. Just as severely low blood pressure indicates the heart is struggling to pump blood to vital organs, negative equity of this magnitude indicates the business has consumed far more value than it has created. This has been worsening steadily over the past decade like a chronic, untreated condition.
• Cash Reserves (Hydration): £232 — Critically low. With only £232 in the bank, the company is profoundly dehydrated. This is barely enough to cover a cup of coffee, let alone any unexpected costs, representing an extreme vulnerability to even minor financial shocks.
• Current Ratio (Pulse Rate): 0.03 — Calculated as Current Assets (£21,351) divided by Current Liabilities (£780,379). A healthy pulse is typically above 1.0, meaning you have enough current assets to cover near-term debts. A pulse of 0.03 means the company has roughly 3 pence for every pound it owes in the next 12 months.
• Director Loan Dependency (Life Support): £778,646 — The vast majority of the company's liabilities (nearly £780k) are owed to director M. Samuelson. This is the financial equivalent of being on a ventilator; the company is entirely reliant on this external oxygen supply to breathe.

Diagnosis

Chronic Insolvency with Director-Dependent Stabilization

The financial data reveals a business that is fundamentally unwell from a balance sheet perspective, yet has been kept in a state of suspended animation by its directors. For at least the last ten years, the company has suffered from worsening negative equity (bleeding net assets from -£416k in 2016 to -£756k in 2025).

The primary symptom of distress is the massive accumulation of debt owed to the director (£778,646). In medical terms, the director is acting as both the primary surgeon and the blood donor. Because the director has not demanded repayment and has continued to advance small amounts of cash (£9,377 this year), the company avoids formal insolvency. The directors have explicitly stated in the accounts that they will continue to support the company, which is the only justification for preparing the accounts on a "going concern" basis. However, if this director support were to be withdrawn, the company would immediately suffer a fatal cardiac arrest (forced liquidation).

The company does hold £20,707 in "stocks" (which, in the film industry, typically represents unamortized production costs), but it is unclear if these assets can be converted into cash quickly enough to pay down short-term obligations. Furthermore, fixed assets (computer equipment) are essentially fully depreciated, holding only a £2,393 book value, meaning the business has aging physical capital.

Recommendations

To stabilize the patient and work towards financial recovery, the following interventions are urgently required:

1. Debt-to-Equity Surgery (Capital Restructuring): The most pressing structural issue is the massive director debt crippling the balance sheet. The directors should formally convert a significant portion of the £778k loan into share capital. This won't change the absolute net asset position immediately, but it will dramatically improve the current ratio and remove the threat of an immediate, callable debt triggering insolvency.
2. Monetize Dormant Assets (Stimulating Circulation): The £20,707 sitting in production stocks needs to be assessed. If these are old or dormant film rights that are unlikely to generate future revenue, they should be written off or sold. If they do have market value, they must be actively exploited to generate cash flow and reduce the reliance on director loans.
3. Cash Flow Resuscitation: With only £232 in the bank, the business cannot afford any unexpected expenses. Management must focus on immediate, cash-generating projects. New production or post-production work should be undertaken only if it guarantees positive cash flow within a very short timeframe.
4. Contingency Planning (Advance Directive): Given the company's total dependency on one individual's financial goodwill, there must be a formalized plan for what happens if that director can no longer provide funding. The other stakeholders (like Ms. Blackburn) must understand the exact conditions under which the life support would be switched off.